Document Classification

Section Type: RESULTS

Text: Twelve-month survival was 28 % [95 % CI 17-41 ; treatment] and 32 % [95 % CI 19-44 ; control] with no significant differences in median OS (5. 0 [95 % CI 3. 7-6. 3] vs. 5. 2 [95 % CI 3. 5-6. 9] months ; p = 0. 87, HR = 1. 04 [95 % CI 0. 7-1. 6]) or TTP (5. 3 [95 % CI 2. 0-8. 6] vs. 2. 9 [95 % CI 2. 6-3. 1] months ; p = 0. 60, HR = 1. 13 [95 % CI 0. 7-1. 8]).